Startups
At Nxera Pharma, our mission is to accelerate the development of life-changing medicines by investing in science and technology. Our world-leading and proprietary NxWave™ platform enables us to unlock the potential of GPCRs to rational structure-based drug design and develop life-changing medicines.
Overview
Location
United Kingdom, England, London
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 26, 2024 | Nexera Pharma Co., Ltd. Receives US$10 million milestone in drug discovery collaboration for neurological diseases with AbbVie | |
| May 30, 2024 | Nexera Pharma Co., Ltd. Expand target disease areas through strategic R&D alliance with PrecisionLife | |
| May 30, 2024 | Nexera Pharma Co., Ltd. Expand target disease areas through strategic R&D alliance with PrecisionLife | Nexera Pharma Co., Ltd. Expand target disease areas through strategic R&D alliance with PrecisionLife Aims to identify novel drug targets by expanding existing collaborations and leveraging new insights in the disease biology of autoimm... |
Reviews 0
FAQ about Nxera Pharma
What has the press written about Nxera Pharma?
Parsers VC has collected 4 articles mentioning Nxera Pharma, among them “Nexera Pharma Co., Ltd. Receives US$10 million milestone in drug discovery collaboration for neurological diseases with AbbVie” (Jun 26, 2024) and “Nexera Pharma Co., Ltd. Expand target disease areas through strategic R&D alliance with PrecisionLife” (May 30, 2024).
Is Nxera Pharma still active?
Yes, Nxera Pharma is active; its latest activity on Parsers VC dates from Jun 26, 2024.